Beta Drugs Ltd
Beta Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Beta Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Beta Drugs Ltd Share Price Chart
Beta Drugs Ltd Fundamentals
Traded Volume: 14,385
Market Cap(Cr): 1,686
Avg Traded Price 669.94
1 Year return -11.63%
Upper Circuit 1,725
Lower Circuit 1,620
P/E TTM 40.00
P/B Ratio 42.00
Traded Value(Cr) 240.26
EPS TTM 42.021
Book value 42.021
Dividend 0.00%
Beta Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Beta Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Beta Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -10.07%
1M -6.39%
3M -3.47%
1Y -11.63%
YTD -7.88%
Beta Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Beta Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 6825.00
Day Before Yesterday 6300.00
1W Avg 4068.75
1M Avg 3335.00
3M Avg 3933.20
Beta Drugs Ltd Technical Details
Beta Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 1618
Support 2 1567
Support 3 1513
Pivot Point : 1672
Resistance 1 1723
Resistance 2 1777
Resistance 3 1828
Beta Drugs Ltd Corporate Actions
Beta Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Beta Drugs Ltd’s capital allocation strategies.
All
Ex-Date 26-Mar-2025 Type B Description share@1:20 Record Date 26-Mar-2025 Ratio 1:20
Dividends
No Dividend has been declared by BETA
Bonus
Record Date 26-Mar-2025 Ex-Bonus Date 26-Mar-2025 Ratio 1:20
Splits
No Split has been declared by BETA
Others
Rights No Rights has been declared by BETA
Beta Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Beta Drugs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Beta Drugs Ltd's relative performance and valuation against major competitors.
Stock Name Amrutanjan Health Care Ltd ₹707.50 (-0.08%) M. Cap (Cr) 20.45 1 Yr Return (%) -4.10% P/E (TTM) 37.51 PB Ratio 6.26
Stock Name Windlas Biotech Ltd ₹869.85 (-5.74%) M. Cap (Cr) 18.33 1 Yr Return (%) -22.92% P/E (TTM) 27.08 PB Ratio 3.87
Stock Name Shukra Pharmaceuticals Ltd ₹40.97 (+1.99%) M. Cap (Cr) 17.94 1 Yr Return (%) +491.20% P/E (TTM) 177.28 PB Ratio 33.05
Stock Name Beta Drugs Ltd ₹1670.20 (-4.01%) M. Cap (Cr) 16.86 1 Yr Return (%) -11.63% P/E (TTM) 39.75 PB Ratio 9.32
Stock Name Syncom Formulations (India) Ltd ₹16.07 (-0.12%) M. Cap (Cr) 15.11 1 Yr Return (%) -24.41% P/E (TTM) 26.24 PB Ratio 4.41
Stock Name Jagsonpal Pharmaceuticals Ltd ₹216.04 (-0.29%) M. Cap (Cr) 14.42 1 Yr Return (%) -11.28% P/E (TTM) 23.27 PB Ratio 7.31
Stock Name Bajaj Healthcare Ltd ₹442.80 (-0.82%) M. Cap (Cr) 13.99 1 Yr Return (%) +15.27% P/E (TTM) 30.51 PB Ratio 3.14
Beta Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Beta Drugs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 18.04 Mar 2024 21.19 Mar 2023 10.23 Mar 2022 18.76 Mar 2021 11.60
PARTICULARS Investing Activities Mar 2025 -21.46 Mar 2024 -11.02 Mar 2023 -5.82 Mar 2022 -12.72 Mar 2021 -3.15
PARTICULARS Financing Activities Mar 2025 118.20 Mar 2024 -0.76 Mar 2023 -2.19 Mar 2022 1.27 Mar 2021 -4.34
PARTICULARS Net Cash Flow Mar 2025 114.79 Mar 2024 9.40 Mar 2023 2.21 Mar 2022 7.31 Mar 2021 4.10
Beta Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Beta Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 66.73%
Public 32.07%
Other Institutions 0.29%
FII 0.9%
Mutual Funds null%
About Beta Drugs Ltd
Beta Drugs Limited was incorporated as a private limited company with the name Beta Drugs Private limited at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to Beta Drugs Limited on August 11, 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Company's products range from anti-cancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. The Company set up the first Oncology Unit in Adley Formulations Pvt Ltd. in 2008. It set up a new state of the art manufacturing facility for oncology formulations in 2014; developed in-house Albumin bound Paclitaxel in 2015; started in-house API Plant - Adley Labs in 2017. In October, 2017, the Company came up with a Public Issue of 22,96,000 Equity Shares by raising equity capital aggregating Rs 19.5 Crores.The Company set up an Oncology Plant in Uzbekistan in 2018. In 2020, the Company launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB; launched 1st Indian Brand of Dasatinib, BEEDAN. In 2025, the Company launched 1st Indian brand of Sunitinib, ADSUNIB.
Whole-time Director
Balwant Singh.
Registered office Village Nandpur, null, Baddi, Himachal Pradesh, 174101
FAX :91-1795-236196
Background
Incorporation Year 2005
Face Value ₹10.00
Market Lot 1600
FAQs on Beta Drugs Ltd
How to buy Beta Drugs Ltd shares on NSE?
To buy Beta Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Beta Drugs Ltd share price today?
The Beta Drugs Ltd share price on NSE is ₹1670.20 today.
What is the market cap of Beta Drugs Ltd on NSE?
The company has a market capitalization of ₹1685.99.
What is the PE & PB ratio of Beta Drugs Ltd?
PE is 40 and PB is 42.
What is the 52 Week High and Low of Beta Drugs Ltd shares?
Beta Drugs Ltd stock price high: ₹2215.24 Beta Drugs Ltd stock price low: ₹1429.52.